J1202 Miglustat oral 65 milligrams
Also known as: Zavesca, miglustat
Miglustat oral capsule supplied in 65 milligram units, an iminosugar for treatment of lysosomal storage disorders.
In Plain Language
Medicine for rare storage disease
Clinical Context
Used for treatment of Gaucher disease and Niemann-Pick disease type C with glucosylceramide synthase inhibition.
RVU Information
CPT J1202 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J1202?
CPT J1202 (Miglustat oral 65 milligrams) is a J Codes (Drugs) code. Miglustat oral capsule supplied in 65 milligram units, an iminosugar for treatment of lysosomal storage disorders.
How is J1202 administered?
CPT J1202 is administered by a healthcare provider, typically via injection or infusion. Used for treatment of Gaucher disease and Niemann-Pick disease type C with glucosylceramide synthase inhibition. It is used by Genetics, Hematology, Internal Medicine.
When is CPT J1202 used?
Used for treatment of Gaucher disease and Niemann-Pick disease type C with glucosylceramide synthase inhibition.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.